Interplay between local versus soluble transforming growth factor-beta and fibrin scaffolds: Role of cells and impact on human mesenchymal stem cell chondrogenesis

Tissue Engineering - Part A

Volumn 18, Issue 11-12, 2012, Pages 1140-1150

  Diederichs, Solvig ^a,b   Baral, Kerstin ^a   Tanner, Michael ^a   Richter, Wiltrud ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE; COLLAGEN; CYTOLOGY; ENZYME INHIBITION; MOLECULES; PEPTIDES; RECOMBINANT PROTEINS; STEM CELLS;

CARTILAGE TISSUE ENGINEERING; CELL SEEDING; CHONDROGENESIS; CHONDROGENIC DIFFERENTIATION; EXTRACELLULAR MATRIX MOLECULES; FIBRIN SCAFFOLD; GROWTH FACTOR; HUMAN MESENCHYMAL STEM CELLS; IN-VITRO; PROTEOGLYCANS; RELEASE KINETICS; RELEASE RATE; STORAGE COMPONENT; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; COLLAGEN TYPE 2; FIBRIN; PROTEOGLYCAN; TISSUE SCAFFOLD; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CHEMISTRY; CHONDROGENESIS; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; HUMAN; HYDROGEL; HYPERTROPHY; KINETICS; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; SOLUBILITY;

BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CHONDROGENESIS; COLLAGEN TYPE II; FIBRIN; HUMANS; HYDROGEL; HYPERTROPHY; KINETICS; MESENCHYMAL STEM CELLS; MIDDLE AGED; PROTEOGLYCANS; SOLUBILITY; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84861802055     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0426     Document Type: Review

References (47)

1. Martin, Y., and Vermette, P. Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 26, 7481, 2005.
2. Meijer, G.J., de Bruijn, J.D., Koole, R., and van Blitterswijk, C.A. Cell based bone tissue engineering in jaw defects. Biomaterials 29, 3053, 2008.
3. Nettles, D.L., Elder, S.H., and Gilbert, J.A. Potential use of chitosan as a cell scaffold material for cartilage tissue engineering. Tissue Eng 8, 1009, 2002.
4. Massam-Wu, T., Chiu, M., Choudhury, R., Chaudhry, S.S., Baldwin, A.K., McGovern, A., Baldock, C., Shuttleworth, C.A., and Kielty, C.M. Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta. J Cell Sci 123, 3006, 2010.
5. Ferrara, N. Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action. Mol Biol Cell 21, 687, 2010.
6. Schultz, G.S., and Wysocki, A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 17, 153, 2009.
7. Schonherr, E., and Hausser, H.J. Extracellular matrix and cytokines: a functional unit. Dev Immunol 7, 89, 2000.
8. Kresse, H., and Schonherr, E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 189, 266, 2001.
9. Wu, Y.J., La Pierre, D.P., Wu, J., Yee, A.J., and Yang, B.B. The interaction of versican with its binding partners. Cell Res 15, 483, 2005.
10. Macri, L., Silverstein, D., and Clark, R.A. Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv Drug Deliv Rev 59, 1366, 2007.
11. Eyrich, D., Brandl, F., Appel, B., Wiese, H., Maier, G., Wenzel, M., Staudenmaier, R., Goepferich, A., and Blunk, T. Long-term stable fibrin gels for cartilage engineering. Biomaterials 28, 55, 2007.
12. McCall, J.D., Lin, C.C., and Anseth, K.S. Affinity peptides protect transforming growth factor beta during encapsulation in poly(ethylene glycol) hydrogels. Biomacromolecules 12, 1051, 2011.
13. Hwang, N.S., Varghese, S., Li, H., and Elisseeff, J. Regulation of osteogenic and chondrogenic differentiation of mesenchymal stem cells in PEG-ECM hydrogels. Cell Tissue Res 344, 499, 2011.
14. Malicev, E., Radosavljevic, D., and Velikonja, N.K. Fibrin gel improved the spatial uniformity and phenotype of human chondrocytes seeded on collagen scaffolds. Biotechnol Bioeng 96, 364, 2007.
15. Eyrich, D., Wiese, H., Maier, G., Skodacek, D., Appel, B., Sarhan, H., Tessmar, J., Staudenmaier, R., Wenzel, M.M., Goepferich, A., and Blunk, T. In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Eng 13, 2207, 2007.
16. Cox, S., Cole, M., and Tawil, B. Behavior of human dermal fibroblasts in three-dimensional fibrin clots: dependence on fibrinogen and thrombin concentration. Tissue Eng 10, 942, 2004.
17. Catelas, I., Dwyer, J.F., and Helgerson, S. Controlled release of bioactive transforming growth factor Beta-1 from fibrin gels in vitro. Tissue Eng Part C Methods 14, 119, 2008.
18. Sharma, B., Williams, C.G., Khan, M., Manson, P., and Elisseeff, J.H. In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel. Plast Reconstr Surg 119, 112, 2007.
19. Giannoni, P., and Hunziker, E.B. Release kinetics of transforming growth factor-beta1 from fibrin clots. Biotechnol Bioeng 83, 121, 2003.
20. Wong, C., Inman, E., Spaethe, R., and Helgerson, S. Fibrinbased biomaterials to deliver human growth factors. Thromb Haemost 89, 573, 2003.
21. Bensaid, W., Triffitt, J.T., Blanchat, C., Oudina, K., Sedel, L., and Petite, H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24, 2497, 2003.
22. Ye, Q., Zund, G., Benedikt, P., Jockenhoevel, S., Hoerstrup, S.P., Sakyama, S., Hubbell, J.A., and Turina, M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 17, 587, 2000.
23. Amrani, D.L., Diorio, J.P., and Delmotte, Y. Wound healing. Role of commercial fibrin sealants. Ann N Y Acad Sci 936, 566, 2001.
24. Haddo, O., Mahroof, S., Higgs, D., David, L., Pringle, J., Bayliss, M., Cannon, S.R., and Briggs, T.W. The use of chondrogide membrane in autologous chondrocyte implantation. Knee 11, 51, 2004.
25. Park, J.S., Yang, H.N., Woo, D.G., Chung, H.M., and Park, K.H. In vitro and in vivo chondrogenesis of rabbit bone marrow-derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles. Tissue Eng Part A 15, 2163, 2009.
26. Guo, X., Liao, J., Park, H., Saraf, A., Raphael, R.M., Tabata, Y., Kasper, F.K., and Mikos, A.G. Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater 6, 2920, 2010.
27. Park, H., Temenoff, J.S., Tabata, Y., Caplan, A.I., Raphael, R.M., Jansen, J.A., and Mikos, A.G. Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A 88, 889, 2009.
28. Zisch, A.H., Schenk, U., Schense, J.C., Sakiyama-Elbert, S.E., and Hubbell, J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72, 101, 2001.
29. Schmoekel, H.G., Weber, F.E., Schense, J.C., Gratz, K.W., Schawalder, P., and Hubbell, J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng 89, 253, 2005.
30. Shah, R.N., Shah, N.A., Rosario Lim, M.M., Hsieh, C., Nuber, G., and Stupp, S.I. Supramolecular design of selfassembling nanofibers for cartilage regeneration. Proc Natl Acad Sci USA 107, 3293, 2010.
31. Dickhut, A., Dexheimer, V., Martin, K., Lauinger, R., Heisel, C., and Richter, W. Chondrogenesis of human mesenchymal stem cells by local TGF-beta delivery in a biphasic resorbable carrier. Tissue Eng Part A 16, 453, 2010.
32. Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O., and Pittenger, M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4, 415, 1998.
33. Hoemann, C.D., Sun, J., Chrzanowski, V., and Buschmann, M.D. A multivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem 300, 1, 2002.
34. Mason, M.N., Metters, A., Bowman, C.N., and Anseth, K.S. Predicting controlled-release behavior of degradable PLA-b-PEG-b-PLA hydrogels. Macromolecules 34, 4630, 2001.
35. Holland, T.A., Tabata, Y., and Mikos, A.G. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 91, 299, 2003.
36. Lutolf, M.P., and Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23, 47, 2005.
37. Eming, S.A., and Hubbell, J.A. Extracellular matrix in angiogenesis: dynamic structures with translational potential. Exp Dermatol 20, 605, 2011.
38. Lee, S.H., and Shin, H. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv Drug Deliv Rev 59, 339, 2007.
39. Chen, T.T., Luque, A., Lee, S., Anderson, S.M., Segura, T., and Iruela-Arispe, M.L. Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells. J Cell Biol 188, 595, 2010.
40. Hennig, T., Lorenz, H., Thiel, A., Goetzke, K., Dickhut, A., Geiger, F., and Richter, W. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211, 682, 2007.
41. Dickhut, A., Gottwald, E., Steck, E., Heisel, C., and Richter, W. Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo. Front Biosci 13, 4517, 2008.
42. Schmitt, C.P., Homme, M., and Schaefer, F. Structural organization and biological relevance of oscillatory parathyroid hormone secretion. Pediatr Nephrol 20, 346, 2005.
43. Homme, M., Schaefer, F., Mehls, O., and Schmitt, C.P. Differential regulation of RGS-2 by constant and oscillating PTH concentrations. Calcif Tissue Int 84, 305, 2009.
44. Hui, M., and Tenenbaum, H.C. New face of an old enzyme: alkaline phosphatase may contribute to human tissue aging by inducing tissue hardening and calcification. Anat Rec 253, 91, 1998.
45. Anderson, H.C., Sipe, J.B., Hessle, L., Dhanyamraju, R., Atti, E., Camacho, N.P., and Millan, J.L. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 164, 841, 2004.
46. Dickhut, A., Pelttari, K., Janicki, P., Wagner, W., Eckstein, V., Egermann, M., and Richter, W. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. J Cell Physiol 219, 219, 2009.
47. Ehrbar, M., Metters, A., Zammaretti, P., Hubbell, J.A., and Zisch, A.H. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 101, 93, 2005.